|
1
|
Criteria for the diagnosis of corticobasal degeneration.
|
Neurology
|
2013
|
3.07
|
|
2
|
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
|
Nat Genet
|
2011
|
2.97
|
|
3
|
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
|
Brain
|
2011
|
2.13
|
|
4
|
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
|
Brain
|
2011
|
1.89
|
|
5
|
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
|
Arch Neurol
|
2005
|
1.82
|
|
6
|
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.
|
Hum Mutat
|
2013
|
1.53
|
|
7
|
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
|
J Neurochem
|
2012
|
1.52
|
|
8
|
[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
|
Mol Med
|
2002
|
1.26
|
|
9
|
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
|
Mov Disord
|
2011
|
1.25
|
|
10
|
Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.
|
J Neurosci
|
2007
|
1.23
|
|
11
|
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment.
|
J Am Geriatr Soc
|
2005
|
1.04
|
|
12
|
Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients.
|
J Neuroinflammation
|
2011
|
1.02
|
|
13
|
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.
|
J Neurochem
|
2004
|
0.99
|
|
14
|
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration.
|
Neurobiol Aging
|
2009
|
0.97
|
|
15
|
Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.
|
J Clin Invest
|
2013
|
0.91
|
|
16
|
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment.
|
Rejuvenation Res
|
2006
|
0.91
|
|
17
|
Topiramate weight loss in migraine patients.
|
J Neurol Sci
|
2008
|
0.91
|
|
18
|
Jugular valve incompetence: a study using air contrast ultrasonography on a general population.
|
J Ultrasound Med
|
2002
|
0.89
|
|
19
|
Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts.
|
Neurobiol Dis
|
2004
|
0.89
|
|
20
|
Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
|
J Alzheimers Dis
|
2011
|
0.88
|
|
21
|
Right hemisphere involvement in non-fluent primary progressive aphasia.
|
Behav Neurol
|
2007
|
0.87
|
|
22
|
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease.
|
Brain
|
2010
|
0.87
|
|
23
|
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
|
Hum Mol Genet
|
2006
|
0.87
|
|
24
|
The speech and language FOXP2 gene modulates the phenotype of frontotemporal lobar degeneration.
|
J Alzheimers Dis
|
2010
|
0.86
|
|
25
|
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia.
|
J Alzheimers Dis
|
2012
|
0.86
|
|
26
|
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.
|
Arch Neurol
|
2002
|
0.86
|
|
27
|
Universal grammar in the frontotemporal dementia spectrum: evidence of a selective disorder in the corticobasal degeneration syndrome.
|
Neuropsychologia
|
2007
|
0.86
|
|
28
|
SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus.
|
Neurobiol Aging
|
2010
|
0.86
|
|
29
|
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.
|
J Neuroinflammation
|
2014
|
0.85
|
|
30
|
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease.
|
Neurobiol Aging
|
2010
|
0.85
|
|
31
|
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.
|
Acta Neuropathol
|
2014
|
0.84
|
|
32
|
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
|
Neurobiol Dis
|
2005
|
0.82
|
|
33
|
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations.
|
Neurosci Lett
|
2007
|
0.82
|
|
34
|
A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.
|
Antioxid Redox Signal
|
2013
|
0.82
|
|
35
|
Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study.
|
Neurol Sci
|
2011
|
0.81
|
|
36
|
Mutual information optimization for mass spectra data alignment.
|
IEEE/ACM Trans Comput Biol Bioinform
|
2011
|
0.81
|
|
37
|
Re: Activities of daily living in frontotemporal dementia and Alzheimer disease.
|
Neurology
|
2007
|
0.80
|
|
38
|
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease.
|
Clin Neurol Neurosurg
|
2008
|
0.80
|
|
39
|
Cognitive reserve in granulin-related frontotemporal dementia: from preclinical to clinical stages.
|
PLoS One
|
2013
|
0.80
|
|
40
|
The usefulness of biological and neuroimaging markers for the diagnosis of early-onset Alzheimer's disease.
|
Int J Alzheimers Dis
|
2011
|
0.80
|
|
41
|
Acute myocardial infarction presenting with transient global amnesia.
|
J Am Geriatr Soc
|
2006
|
0.80
|
|
42
|
Dementia: a new algorithm for molecular diagnostics in FTLD.
|
Nat Rev Neurol
|
2013
|
0.79
|
|
43
|
Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
|
J Alzheimers Dis
|
2013
|
0.79
|
|
44
|
Three sisters covering the transient global amnesia spectrum.
|
Int Psychogeriatr
|
2007
|
0.79
|
|
45
|
[11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis.
|
J Alzheimers Dis
|
2012
|
0.79
|
|
46
|
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment.
|
Curr Alzheimer Res
|
2014
|
0.79
|
|
47
|
TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.
|
J Alzheimers Dis
|
2012
|
0.78
|
|
48
|
Suicide risk in frontotemporal lobe degeneration: to be considered, to be prevented.
|
Alzheimer Dis Assoc Disord
|
2012
|
0.78
|
|
49
|
Frontotemporal Lobar Degeneration.
|
Adv Exp Med Biol
|
2012
|
0.78
|
|
50
|
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins.
|
J Neurol
|
2014
|
0.78
|
|
51
|
The effect of APOE genotype on clinical phenotype in Alzheimer disease.
|
Neurology
|
2007
|
0.78
|
|
52
|
The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
|
J Nucl Med
|
2013
|
0.78
|
|
53
|
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia.
|
Behav Brain Res
|
2013
|
0.78
|
|
54
|
Dementia with Lewy bodies with and without hallucinations: a clue to different entities?
|
Int Psychogeriatr
|
2006
|
0.77
|
|
55
|
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.
|
Parkinsonism Relat Disord
|
2009
|
0.77
|
|
56
|
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway?
|
Neurodegener Dis
|
2015
|
0.76
|
|
57
|
Structural brain signature of FTLD driven by Granulin mutation.
|
J Alzheimers Dis
|
2013
|
0.76
|
|
58
|
Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease.
|
J Transl Med
|
2005
|
0.76
|
|
59
|
Detection of intracranial venous reflux in patients of transient global amnesia.
|
Neurology
|
2007
|
0.76
|
|
60
|
The other face of the coin: the caregiver burden in frontotemporal lobar degeneration.
|
Int J Geriatr Psychiatry
|
2013
|
0.76
|
|
61
|
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study.
|
Neurobiol Aging
|
2013
|
0.76
|
|
62
|
PGRN mutations in northern Italy.
|
Alzheimer Dis Assoc Disord
|
2009
|
0.75
|
|
63
|
Reply to "Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?".
|
Neurobiol Aging
|
2011
|
0.75
|
|
64
|
EEG and granular osmiophilic elements in early-onset Alzheimer's disease.
|
Neurodegener Dis
|
2011
|
0.75
|
|
65
|
Multiple system atrophy due to prolonged valproic acid treatment.
|
Int Psychogeriatr
|
2007
|
0.75
|
|
66
|
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
|
Biomarkers
|
2015
|
0.75
|
|
67
|
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study.
|
Neurodegener Dis
|
2016
|
0.75
|
|
68
|
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series.
|
Psychother Psychosom
|
2017
|
0.75
|
|
69
|
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
|
Neurodegener Dis
|
2017
|
0.75
|
|
70
|
Tau missing from CSF: a case report.
|
J Neurol
|
2007
|
0.75
|
|
71
|
"Alien face" in corticobasal degeneration syndrome: extending clinical features.
|
Int Psychogeriatr
|
2007
|
0.75
|
|
72
|
A case report: doctor, my daughter has Alzheimer's disease.
|
J Am Geriatr Soc
|
2003
|
0.75
|
|
73
|
Catechol-o-methyltransferase gene polymorphism in dementia with Lewy bodies-related psychosis: evidence for a genetic predisposition.
|
Int Psychogeriatr
|
2006
|
0.75
|
|
74
|
Advances on biological markers in early diagnosis of Alzheimer disease.
|
Adv Clin Chem
|
2005
|
0.75
|
|
75
|
Two sequential Tc-99m ECD SPECT studies in a case of sporadic Creutzfeldt-Jakob disease confirmed at autopsy.
|
Clin Nucl Med
|
2011
|
0.75
|